Treatment guidelines for community-acquired Pneumonia in Korea: An evidence-based approach to appropriate antimicrobial therapy

Abstract

A successful therapy of community-acquired pneumonia requires appropriate empirical antimicrobial remedies. Etiology and antimicrobial susceptibility of major pathogens of pneumonia can differ by country. Therefore, an ideal treatment guideline of community-acquired pneumonia in a country should be based on the studies performed in individual countries. We have developed a treatment guideline for community-acquired pneumonia in immunocompetent adults in Korea. This guideline was developed by the joint committee of the Korean Society for Chemotherapy, the Korean Society of Infectious Diseases, and the Korean Academy of Tuberculosis and Respiratory diseases.